$8.1M Financing & Re-Set of Capital Structure
Filed with ASX · · 3 pages · English
Earlier from Noxopharm
- Noxopharm Dec 2019 Appendix 4C
- Listing of Nyrada Inc. spin-off on ASX
- DARRT-1 Clinical Data Webinar
- Nyrada IPO Offer Fully Subscribed
- Lodgement of Nyrada Inc Supplementary Prospectus
Later from Noxopharm
- LuPIN Trial Interim Results Indicate Striking Survival Benefit
- Noxopharm Alliance With GenesisCare
- FDA grants IND approval to Veyonda
- Half Year Accounts and Chairman Letter
- LuPIN Prostate Cancer Trial Fully Recruited
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm